Companies: 10,795·Total market cap: $144.5T
Prime Medicine, Inc.

Prime Medicine, Inc.

PRMENASDAQHealthcare● Active
$3.02
$-0.05(-1.47%)
Market Cap$544561612
P/E Ratio
52W High$6.94
52W Low$1.305
Overview

Prime Medicine, Inc.(PRME)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PRME · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$4.63M$2.98M$0.00M$0.00M$0.00M
Cost of Revenue$7.32M$0.00M$0.00M$0.00M$0.00M
Gross Profit($2.69M)$2.98M$0.00M$0.00M$0.00M
Gross Margin %(computed)-58.05%100.00%
Operating Expenses
R&D Expenses$160.64M$155.29M$147.91M$86.72M$70.55M
G&A Expenses$52.35M$50.16M$43.39M$29.82M$13.92M
Total Operating Expenses$205.66M$205.45M$204.79M$116.54M$84.47M
Operating Income($208.35M)($202.47M)($204.79M)($116.54M)($84.47M)
Operating Margin %(computed)
Interest Income$4.15M$3.52M$0.00M$0.00M$0.00M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($201.14M)($195.88M)($198.41M)($122.77M)($165.85M)
Income Tax Expense$0.00M$0.00M($0.28M)($0.95M)($0.49M)
Net Income($201.14M)($195.88M)($198.13M)($121.82M)($165.37M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.35$-1.65$-2.18$-1.46$-1.92
Wtd Avg Shares148.76M118.60M90.97M97.21M95.73M
EBITDA($195.76M)($196.34M)($186.64M)($114.32M)($83.91M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Prime Medicine, Inc.

关于Prime Medicine, Inc.(PRME)损益表

Prime Medicine, Inc.(PRME)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,PRME实现营收$0.00B,毛利润($0.00B)(毛利率-58.05%),净利润($0.20B)(净利率-4342.44%)。

常见问题

PRME · 4 问

Prime Medicine, Inc.(PRME)2025财年营收为$0.00B,同比up55.3%。

PRME revenuePRME salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08